At a glance
What is it—and why does it matter?
Octreotide acetate is stated to suppress pituitary secretion of thyroid stimulating hormone (TSH). Subcutaneous octreotide shows rapid, complete absorption; for a 100 mcg dose the reported Cmax is 5.2 ng/mL at 0.4 hours post-dose.
Sources for this introduction: [1] [2]
This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.
What is it?
A molecule, not a product name.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
How does it work?
Target, response, and disposition.
Pharmacokinetics
Subcutaneous octreotide shows rapid, complete absorption; for a 100 mcg dose the reported Cmax is 5.2 ng/mL at 0.4 hours post-dose.
- Reported result
- Peak concentrations of 5.2 ng/mL
- Source records
- 1
- Regulatory records
- 1
Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.
Exact passages, locators, and provenance
- supports · Source-backed record
“After subcutaneous injection, octreotide is absorbed rapidly and completely from the injection site. Peak concentrations of 5.2 ng/mL (100 mcg dose) were reached 0.4 hours after dosing.”
Rx OnlyPrescribing Information · CLINICAL PHARMACOLOGY
dailymed:6b55eedd-4160-49f8-966b-55b0e60a4b06:97eb8c6215c1:97eb8c6215c1
What has been studied?
What the evidence says.
Study findings
Octreotide acetate is stated to suppress pituitary secretion of thyroid stimulating hormone (TSH).
- Source records
- 1
- Regulatory records
- 1
Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.
Exact passages, locators, and provenance
- supports · Source-backed record
“Octreotide acetate suppresses secretion of thyroid stimulating hormone (TSH).”
Rx OnlyPrescribing Information · CLINICAL PHARMACOLOGY
dailymed:6b55eedd-4160-49f8-966b-55b0e60a4b06:97eb8c6215c1:97eb8c6215c1
Risks and interactions
Risks, organized for scanning.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Products and regulatory status
Same ingredient. Different records.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Administration context
The practical clinical context.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Research status + gaps
What still needs better answers?
- No publishable claim yet for: administration, contraindication, identity, interaction, mechanism, regulatory, safety
- 12 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (8), assurance_score_below_0.72 (3), current_regulatory_source_required (2), extraction_ambiguity (12), high_risk_requires_regulatory_or_two_independent_sources (3), no_direct_support (11)
These are the limits of this profile, not an exhaustive list of scientific uncertainties.
References + discovery
Open the records yourself.
- Rx OnlyPrescribing Information ↗
dailymed · published 2018-09-21 · retrieved 2026-09-01T08:37:10Z
Publication history and provenance
Version 3 · Automated assessment · 2026-09-01T08:37:10Z
116a981be02ad13c349975642ca3c54d9539c95ead66b00d26a9ca1b08f3cbb8